Aster DM Healthcare Ltd. · NSE:ASTERDM
Aster DM Healthcare — Aster DM Quality Care — Q2 FY27 Earnings Presentation
29 slides from Aster DM Healthcare's earnings presentation, Nov 6, 2026
Slide 1: Stock exchange filing cover letter
6 November 2026 BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051, Maharashtra, India Maharashtra, India Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/Madam, Sub: Inv
Slide 2: Earnings Presentation Q2 & H1 FY27
Earnings Presentation Q2 & H1 FY27
Slide 3: Disclaimer
Disclaimer • This presentation has been prepared by Aster DM Quality Care Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other cond
Slide 4: Days Together
100 Days Together #GoGreater One Team One Culture One team across Aster, CARE, Evercare and KIMSHEALTH 33
Slide 5: Days Together: Building One Organisation under #GoGreater
100 S i nce 1 July 2026 Days 98% of surveyed employees feel energised by GO GREATER Together High engagement across clusters, functions and tenure Building one organisation under #GoGreater 2.2 mn1 18 50+ Patients served Culture engagements Townhalls conducted together with every employee across uni
Slide 6: Highest Revenue, Op EBITDA and Margin in the First Quarter of the Merger
Highest Revenue, Op EBITDA and Margin in the First Quarter of the Merger INR 2,829 Cr INR 678 Cr 24.0 % INR 281 Cr Revenue Op EBITDA1 Op EBITDA margin Normalised PAT2 +19% YoY growth +25% YoY growth +111 bps YoY +34% YoY; Margin 9.9% 1,200 Sustained Growth Momentum 24.0% Strong growth since the merg
Slide 7: Well Positioned to Unlock Value through Synergies
Well Positioned to Unlock Value through Synergies INR 16.6 Cr of synergies realised in Q2 FY27 Academics, Nursing Business KPI & & Talent Sharing Reporting Standardization Renewable Energy Savings Material Cost Optimization Indirect Cost Optimisation Full Synergy Potential International Medical Tour
Slide 8: Overview and Financial Performance
Overview and Financial Performance 77
Slide 9: 19% Revenue Growth led by 12% rise in Patient Volumes
19% Revenue Growth led by 12% rise in Patient Volumes Revenue1 Operating EBITDA1,2 Op EBITDA Margin1,2 Normalised PAT3 Financial Q2FY27 : INR 2,829 Cr Q2FY27 : INR 678 Cr Q2FY27 : 24.0% Q2FY27 : INR 281 Cr 19% 25% 111 bps 34% Q2FY26 : INR 2,382 Cr Q2FY26 : INR 545 Cr Q2FY26 : 22.9% Q2FY26 : INR 210
Slide 10: Complex Care, Operating Leverage and Synergies Drive Quarterly Performance
Complex Care, Operating Leverage and Synergies Drive Quarterly Performance Strong double-digit revenue growth driven by steady total patient volumes growth and clinical complexity o 19% YoY growth in Revenue, reaching INR 2,829 Cr in Q2 FY27 driven by 12% growth in patient volumes while 4% growth in
Slide 11: 10,840 Beds Across 27 Cities Provide Scale with a Strong Non-Metro Presence
10,840 Beds Across 27 Cities Provide Scale with a Strong Non-Metro Presence 24% - Metro 10,840 Capacity Beds 76% - Non-Metro 27 9 Cities States International Hospitals: 2, Beds: 621 382 332 Labs & PECs3 and Madhya Pradesh Hospitals 2034 Pharmacies Hospitals: 1, Beds: 222 Dhaka Chhattisgarh Indor e H
Slide 12: Invested INR 600+ Crores in Medical Technology in the last 8 months
Invested INR 600+ Crores in Medical Technology in the last 18 months to Drive Complex Care Growth Additions in Q2 FY27 1 LINAC, 1 PET-CT (Digital), 1 Robot at CARE Raipur | 2 Robots at CARE Banjara & MIMS Kannur | 2 Cath labs at CARE Bhubaneswar & MIMS Areekode | 1 MRI at Aster CMI Da Vinci Xi robot
Slide 13: Clinical Firsts and Shared Expertise Expand Access to Advanced Care
Clinical Firsts and Shared Expertise Expand Access to Advanced Care All our hospitals in India are NABH accredited NABH (National Accreditation Board for Hospitals & Healthcare Providers) independently assesses patient safety, care quality and hospital processes. INDIA’S NanoKnife surgery INDIA’S Tw
Slide 14: New Centres of Excellence Deepen Specialty Services Within Existing Hospitals
New Centres of Excellence Deepen Specialty Services Within Existing Hospitals Select Centre of Excellence (CoE) Selected COElaunches inQ2 launches in Q2FY27 FY27 expanded expand service services offerings at existing across existing hospitals hospitals Clinical capabilities Intended contribution to
Slide 15: 16% Growth in CONGO Revenue, Alongside a Shift Towards TPA Payors
16% Growth in CONGO Revenue, Alongside a Shift Towards TPA Payors Payor Revenue Mix Specialty-wise Revenue Mix Q2FY27 [Q2FY26] MVT1 Government 4% [4%] Cardiac Sciences, Health Schemes 15% [16%] 9% [9%] Walk In Others 54% [56%] 30% [30%] Oncology, 9% [9%] Child & Adolescent Neuro Sciences, health, 4%
Slide 16: Mature Hospitals Anchor Earnings as Emerging Units Ramp Up Rapidly
Mature Hospitals Anchor Earnings as Emerging Units Ramp Up Rapidly Key Performance indicators (H1FY27) Maturity Operational Beds5 Total Patient Operating Revenue6 Operating EBITDA6 Volume (mn) EBITDA % 6 2.99 Mature 1 64% 73% 83% 30.2% 11% 18% 25% 186 bps Led by volume and case complexity 0.48 18.6%
Slide 17: P&L and Balance Sheet
P&L and Balance Sheet in INR Cr Profit and Loss Statement Q2FY27 Q2FY26 YoY % H1FY27 H1FY26 YoY % Balance Sheet As on Sep 30, 2026 Liabilities Revenue from operations 2,829 2,382 19% 5,429 4,538 20% Shareholders’ equity 891 Gross margin 2,216 1,848 20% 4,240 3,509 21% Minority interest 1,439 Other r
Slide 18: Building a 15,000+ Bed Healthcare Network
Building a 15,000+ Bed Healthcare Network to Serve India’s Growing Healthcare Needs Addition of 4,230 beds taking total bed capacity to over 15,000 Greenfield 1,676 15,070 Brownfield 1,011 770 665 1,330 760 454 570 10,840 Current FY27 FY28 FY29 FY30 & Beyond Projected 47% Beds in Existing facilities
Slide 19: Complex Care Achievements Across the Network Gain Media Recognition
Complex Care Achievements Across the Network Gain Media Recognition Aster MIMS Kozhikode | Robotic heart defect repair CARE Hyderabad | ABO-incompatible kidney transplant Ramkrishna CARE Raipur | Cancer institute inaugurated by CM CARE Hyderabad | VNS therapy for epilepsy CARE Hyderabad | Rare parat
Slide 20: National and International Recognition Reinforces the Group's Healthcare Credentials
National and International Recognition Reinforces the Group’s Healthcare Credentials Dr. Azad Moopen Varun Khanna Alisha Moopen Dr. M. I. Sahadulla Executive Chairman Managing Director & Executive Director Chairman – Medical Group CEO Advisory Board Lifetime achievement in Social Responsibility Heal
Slide 21: Double-Digit Growth Across All Geographies Underscores Broad-Based Momentum
Double-Digit Growth Across All Geographies Underscores Broad-Based Momentum (Q2 FY27) Kerala and Tamil Nadu South-West and Central South-East Karnataka, Maharashtra, Andhra Pradesh, Telangana, Kerala and Tamil Nadu Madhya Pradesh and Odisha and Bangladesh Chhattisgarh Revenue1▲ 23% YoY Revenue1▲ 16%
Slide 22: An Experienced Board Providing Oversight and Direction
An Experienced Board Providing Oversight and Direction Varun Khanna Alisha Moopen Ayshwarya Vikram Managing Director and Executive Director Non-Executive Director Group CEO Ganesh Mani James Mathew Kewal Handa Non-Executive Director Independent Director Independent Director Sunil Theckath Neela Bhat
Slide 23: A Unified Leadership Team Driving Integration and Growth
A Unified Leadership Team Driving Integration and Growth Sunil Kumar M R Hemish Purushottam Ramesh Kumar Group Company Secretary and Chief Executive Officer Chief Financial Officer Compliance Officer (India I) Dr Ratnadeep Dr Pawan Kumar Vishal Maheshwari Chief Executive Officer Chief Executive Offi
Slide 24: Annexure
Annexure | Aster DM Quality Care Limited
Slide 25: 20% Revenue Growth led by 13% rise in Patient Volumes (H1FY27)
20% Revenue Growth led by 13% rise in Patient Volumes (H1FY27) Revenue1 Operating EBITDA1,2 Op EBITDA Margin1,2 Normalised PAT3 Financial H1FY27 : INR 5,429 Cr H1FY27 : INR 1,255 Cr H1FY27 : 23.1% H1FY27 : 457 Cr 20% 27% 135 bps 27% H1FY26 : INR 4,538 Cr H1FY26 : INR 988 Cr H1FY26 : 21.8% H1FY26 : I
Slide 26: 19% Growth in CONGO Revenue, Alongside a Shift Towards TPA Payors (H1 FY27)
19% Growth in CONGO Revenue, Alongside a Shift Towards TPA Payors (H1 FY27) Payor Revenue Mix Specialty-wise Revenue Mix MVT1 H1FY27 [H1FY26] 4% [3%] Government Cardiac Sciences, Health Schemes 15% [16%] 9% [9%] Others 30% [30%] Oncology, 9% [9%] Walk In 54% [56%] Child & Adolescent health, Neuro Sc
Slide 27: Double-Digit Growth Across All Geographies (H1 FY27)
Double-Digit Growth Across All Geographies Underscores Broad-Based Momentum (H1 FY27) Kerala and Tamil Nadu South-West and Central South-East Karnataka, Maharashtra, Andhra Pradesh, Kerala and Tamil Madhya Pradesh and Telangana, Odisha Nadu Chhattisgarh and Bangladesh Revenue1▲ 24% YoY Revenue1▲ 15%
Slide 28: Current Shareholding Pattern and Key Large Shareholders
Current Shareholding Pattern and Key Large Shareholders Shareholding pattern Key Institutional Shareholders Others 10% Promoter FII* Group 14% 54% DII 22% As on 30th Sep 2026 * Includes TPG 27 27
Slide 29: Thank You
THANK YOU
Aster DM Quality Care — Q2 FY27 Earnings Presentation on 6ix